⚠️ This provider averages 1.3K services per working day — physically unusual for an individual practitioner
Based on 3.2M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $27.2M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 1.3K services per working day raises questions about billing patterns.
Medicare payments to this provider grew 8942% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 2211% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $218.50 | $80.00 | 2.73x | $138.50 | $53.1K | 664 | 8 |
| 2015 | $190.37 | $69.51 | 2.74x | $120.86 | $56.0K | 805 | 11 |
| 2016 | $32.62 | $9.24 | 3.53x | $23.38 | $1.3M | 139.9K | 64 |
| 2017 | $36.82 | $11.05 | 3.33x | $25.77 | $2.2M | 199.1K | 68 |
| 2018 | $24.25 | $6.92 | 3.50x | $17.33 | $2.6M | 382.5K | 75 |
| 2019 | $23.91 | $7.52 | 3.18x | $16.39 | $3.3M | 442.5K | 67 |
| 2020 | $25.94 | $7.89 | 3.29x | $18.05 | $4.1M | 523.6K | 69 |
| 2021 | $31.39 | $9.06 | 3.46x | $22.33 | $4.3M | 474.9K | 62 |
| 2022 | $30.23 | $8.60 | 3.52x | $21.63 | $4.3M | 504.5K | 56 |
| 2023 | $33.80 | $9.47 | 3.57x | $24.33 | $4.8M | 507.1K | 49 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9299 | Injection, nivolumab, 1 mg | 264.3K | $6.0M | $22.77 | 3.09x |
| J9271 | Injection, pembrolizumab, 1 mg | 129.4K | $5.4M | $41.48 | 3.08x |
| J0897 | Injection, denosumab, 1 mg | 215.6K | $3.4M | $15.84 | 2.75x |
| J2505 | Injection, pegfilgrastim, 6 mg | 570 | $1.8M | $3.1K | 3.04x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 12.2K | $1.1M | $86.83 | 3.33x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 124.0K | $1.1M | $8.52 | 2.78x |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 23.7K | $821.2K | $34.71 | 3.00x |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 1.1M | $751.7K | $0.69 | 4.30x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 6.6K | $695.3K | $105.59 | 3.76x |
| 78815 | Nuclear medicine study with ct imaging skull base to mid-thigh | 573 | $500.4K | $873.30 | 3.96x |
| J9310 | Injection, rituximab, 100 mg | 419 | $263.2K | $628.12 | 2.24x |
| J9041 | Injection, bortezomib, 0.1 mg | 12.2K | $249.9K | $20.49 | 5.43x |
| J9025 | Injection, azacitidine, 1 mg | 197.3K | $216.3K | $1.10 | 6.13x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 24.9K | $214.1K | $8.58 | 3.38x |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 1.3K | $210.2K | $157.83 | 3.22x |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 3.4K | $197.5K | $58.67 | 3.39x |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | 1.2K | $195.2K | $160.29 | 3.25x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 3.4K | $195.2K | $58.21 | 3.42x |
| J0185 | Injection, aprepitant, 1 mg | 135.5K | $194.0K | $1.43 | 3.76x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 500 | $189.6K | $379.18 | 1.79x |
This provider submits charges 3.42 times higher than what Medicare actually pays.
A markup ratio of 3.42x means for every $100 Medicare pays, this provider initially charges $342. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in FL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Christopher Lobo, MD | Port Charlotte, FL | $60.5M | ⚠️ Flagged |
| Maen Hussein, M.D. | Tavares, FL | $57.6M | ✓ Clear |
| Vikas Malhotra, M.D. | Spring Hill, FL | $52.8M | ✓ Clear |
| Andrew Lipman, M.D. | Naples, FL | $51.1M | ⚠️ Flagged |
| Syed Zafar, M.D. | Fort Myers, FL | $48.1M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data